Polo-like kinase 2 promotes chemoresistance and predicts limited survival benefit from adjuvant chemotherapy in colorectal cancer
Yuquan Xie(First People’s Hospital of Jingmen), Jianming Chen(Fujian University of Traditional Chinese Medicine)
Cited by 21